Clinical Trial Update: Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly intravenous topotecan in patients with recurrent or persistent endometrial cancer has completed, with results posted. The spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Endometrial, Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-01-28